Merck & Co Inc (NYSE:MRK)

Real-Time Quotes

105.02

BATS BZX Real-Time Price

As of 11:38am ET

-0.51 / -0.48%

Today’s Change

80.74

Today|||52-Week Range

115.49

-5.34%

Year-to-Date

Latest MRK News | Press Releases

Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock 8:20am / MotleyFool.com - Paid Partner Content	Merck (MRK) Stock Sinks As Market Gains: What You Should Know Mar 21 / Zacks.com - Paid Partner Content
Merck (MRK) Dips More Than Broader Markets: What You Should Know Mar 28 / Zacks.com - Paid Partner Content	Top Research Reports for Merck, Intel & MercadoLibre Mar 21 / Zacks.com - Paid Partner Content
GSK's Jemperli Effective Against First-Line Endometrial Cancer Mar 28 / Zacks.com - Paid Partner Content	Is the Best-Performing Dow Stock of the Past Year a Buy? Mar 21 / MotleyFool.com - Paid Partner Content
Should Invesco Dynamic Large Cap Value ETF (PWV) Be on Your Investing Radar? Mar 28 / Zacks.com - Paid Partner Content	Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023? Mar 20 / Zacks.com - Paid Partner Content
Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug Mar 27 / Zacks.com - Paid Partner Content	Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)? Mar 20 / Zacks.com - Paid Partner Content
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know Mar 27 / Zacks.com - Paid Partner Content	Is Invesco Dynamic Large Cap Value ETF (PWV) a Strong ETF Right Now? Mar 20 / Zacks.com - Paid Partner Content
Is Nuveen ESG Large-Cap Value ETF (NULV) a Strong ETF Right Now? Mar 27 / Zacks.com - Paid Partner Content	Could This Be Merck's Next Blockbuster Drug? Mar 18 / MotleyFool.com - Paid Partner Content
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence Mar 24 / MotleyFool.com - Paid Partner Content	Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study Mar 17 / Zacks.com - Paid Partner Content
Sanofi (SNY) Moves 6.0% Higher: Will This Strength Last? Mar 24 / Zacks.com - Paid Partner Content	Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote Mar 17 / Zacks.com - Paid Partner Content
Here's Why You Should Add Novo (NVO) Stock to Your Portfolio Mar 22 / Zacks.com - Paid Partner Content	Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates Mar 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton Mar 22 / Zacks.com - Paid Partner Content	This High-Growth Company Is Expanding. Time to Buy the Stock? Mar 16 / MotleyFool.com - Paid Partner Content